Status:
COMPLETED
Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics
Lead Sponsor:
New York State Psychiatric Institute
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
18-79 years
Phase:
PHASE2
Brief Summary
This study will determine whether combination treatment driven by patient choice is better than standardized medication treatment at retaining and improving Hispanic patients with major depressive dis...
Detailed Description
Retention of Hispanics in the treatment of major depressive disorder (MDD) continues to be a major public health problem. Hispanics drop out from treatment two to three times more frequently than non-...
Eligibility Criteria
Inclusion
- Hispanic males and females
- DSM-IV criteria for non-psychotic major depressive disorder (MDD) of at least moderate severity (HAM-D-17\> 18)
- 18- 79
- Patients with stable dosage of Benzodiazepines to treat anxiety disorders
Exclusion
- At risk of attempting suicide
- Unstable medical illness
- History of bipolar disorder, schizophrenia, or other psychotic disorder
- Pregnant or lactating
- Alcohol or substance use disorder that requires acute detoxification
Key Trial Info
Start Date :
August 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 10 2014
Estimated Enrollment :
170 Patients enrolled
Trial Details
Trial ID
NCT00742573
Start Date
August 1 2008
End Date
January 10 2014
Last Update
March 3 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York State Psychiatric Institute
New York, New York, United States, 10032